Sunday, May 3, 2026

#TAST

9 articles

Meta Platforms And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Meta Platforms And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Apr 3, 2024

TriMas Corporation And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

TriMas Corporation And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Feb 27, 2024

Eli Lilly and Company And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Eli Lilly and Company And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Feb 22, 2024

SCYNEXIS And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

SCYNEXIS And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Feb 18, 2024

Corcept Therapeutics Incorporated And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Corcept Therapeutics Incorporated And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Dec 25, 2023

Sterling Construction Company And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Sterling Construction Company And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Dec 12, 2023

DexCom And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

DexCom And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Dec 8, 2023

SCYNEXIS And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

SCYNEXIS And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Nov 28, 2023

Bionano Genomics And TOR Minerals International On The List Of Winners And Losers Of Monday's US Session

Bionano Genomics And TOR Minerals International On The List Of Winners And Losers Of Monday's US Session

ViaNews Editorial Team•Apr 24, 2023